139 related articles for article (PubMed ID: 9128318)
1. Minimum inhibitory concentration of various single agents and the effect of their combinations against Helicobacter pylori, as estimated by a fast and simple in vitro assay method.
Bamba H; Kondo Y; Wong RM; Sekine S; Matsuzaki F
Am J Gastroenterol; 1997 Apr; 92(4):659-62. PubMed ID: 9128318
[TBL] [Abstract][Full Text] [Related]
2. A novel colorimetric broth microdilution method to determine the minimum inhibitory concentration (MIC) of antibiotics and essential oils against Helicobacter pylori.
Weseler A; Geiss HK; Saller R; Reichling J
Pharmazie; 2005 Jul; 60(7):498-502. PubMed ID: 16076074
[TBL] [Abstract][Full Text] [Related]
3. Bactericidal activity of lansoprazole and omeprazole against Helicobacter pylori in vitro.
Vogt K; Hahn H
Arzneimittelforschung; 1998 Jun; 48(6):694-7. PubMed ID: 9689430
[TBL] [Abstract][Full Text] [Related]
4. The importance of the level of metronidazole resistance for the success of Helicobacter pylori eradication.
Wheeldon TU; Granström M; Hoang TT; Phuncarg DC; Nilsson LE; Sörberg M
Aliment Pharmacol Ther; 2004 Jun; 19(12):1315-21. PubMed ID: 15191514
[TBL] [Abstract][Full Text] [Related]
5. The effect of culture results for Helicobacter pylori on the choice of treatment following failure of initial eradication.
Avidan B; Melzer E; Keller N; Bar-Meir S
Isr Med Assoc J; 2001 Mar; 3(3):163-5. PubMed ID: 11303370
[TBL] [Abstract][Full Text] [Related]
6. The role of active efflux in antibiotic - resistance of clinical isolates of Helicobacter pylori.
Falsafi T; Ehsani A; Niknam V
Indian J Med Microbiol; 2009; 27(4):335-40. PubMed ID: 19736403
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo anti-Helicobacter pylori activity of Calophyllum brasiliense Camb.
Souza Mdo C; Beserra AM; Martins DC; Real VV; Santos RA; Rao VS; Silva RM; Martins DT
J Ethnopharmacol; 2009 Jun; 123(3):452-8. PubMed ID: 19501278
[TBL] [Abstract][Full Text] [Related]
8. In vitro anti-Helicobacter pylori activity of usnic acid.
Safak B; Ciftci IH; Ozdemir M; Kiyildi N; Cetinkaya Z; Aktepe OC; Altindis M; Asik G
Phytother Res; 2009 Jul; 23(7):955-7. PubMed ID: 19367654
[TBL] [Abstract][Full Text] [Related]
9. In vitro anti-Helicobacter pylori activity of some flavonoids and their metabolites.
Bae EA; Han MJ; Kim DH
Planta Med; 1999 Jun; 65(5):442-3. PubMed ID: 10454900
[TBL] [Abstract][Full Text] [Related]
10. Non-steroidal anti-inflammatory drugs have bacteriostatic and bactericidal activity against Helicobacter pylori.
Shirin H; Moss SF; Kancherla S; Kancherla K; Holt PR; Weinstein IB; Sordillo EM
J Gastroenterol Hepatol; 2006 Sep; 21(9):1388-93. PubMed ID: 16911681
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of faropenem in eradication therapy of Helicobacter pylori.
Ogura K; Mitsuno Y; Maeda S; Hirata Y; Yanai A; Shibata W; Ohmae T; Yoshida H; Kawabe T; Omata M
Helicobacter; 2007 Dec; 12(6):618-22. PubMed ID: 18001403
[TBL] [Abstract][Full Text] [Related]
12. Vitamin C inhibits the growth of a bacterial risk factor for gastric carcinoma: Helicobacter pylori.
Zhang HM; Wakisaka N; Maeda O; Yamamoto T
Cancer; 1997 Nov; 80(10):1897-903. PubMed ID: 9366290
[TBL] [Abstract][Full Text] [Related]
13. Resistance rate to antibiotics of Helicobacter pylori isolates in eastern Taiwan.
Hu CT; Wu CC; Lin CY; Cheng CC; Su SC; Tseng YH; Lin NT
J Gastroenterol Hepatol; 2007 May; 22(5):720-3. PubMed ID: 17444862
[TBL] [Abstract][Full Text] [Related]
14. Bacteriostatic and bactericidal activity of ranitidine bismuth citrate in Helicobacter pylori clinical isolates.
Alarcón T; Domingo D; Prieto N; López-Brea M
Rev Esp Quimioter; 1999 Mar; 12(1):64-8. PubMed ID: 10209056
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the E test and agar dilution method for antimicrobial suceptibility testing of Helicobacter pylori.
Glupczynski Y; Broutet N; Cantagrel A; Andersen LP; Alarcon T; López-Brea M; Mégraud F
Eur J Clin Microbiol Infect Dis; 2002 Jul; 21(7):549-52. PubMed ID: 12172749
[TBL] [Abstract][Full Text] [Related]
16. Antibacterial activity of Tabebuia impetiginosa Martius ex DC (Taheebo) against Helicobacter pylori.
Park BS; Lee HK; Lee SE; Piao XL; Takeoka GR; Wong RY; Ahn YJ; Kim JH
J Ethnopharmacol; 2006 Apr; 105(1-2):255-62. PubMed ID: 16359837
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial activity of aminoreductone against Helicobacter pylori.
Trang VT; Takeuchi H; Kudo H; Aoki A; Katsuno S; Shimamura T; Sugiura T; Ukeda H
J Agric Food Chem; 2009 Dec; 57(23):11343-8. PubMed ID: 19891477
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of Lactobacillus acidophilus on Helicobacter pylori in peptic ulcer patients: in vitro study.
Vilaichone RK; Mahachai V; Tumwasorn S; Nunthapisud P; Kullavanijaya P
J Med Assoc Thai; 2002 Jun; 85 Suppl 1():S79-84. PubMed ID: 12188456
[TBL] [Abstract][Full Text] [Related]
19. Susceptibility of Helicobacter pylori to metronidazole.
Perna F; Gatta L; Figura N; Ricci C; Tampieri A; Holton J; Miglioli M; Vaira D
Am J Gastroenterol; 2003 Oct; 98(10):2157-61. PubMed ID: 14572561
[TBL] [Abstract][Full Text] [Related]
20. [Helicobacter pylori and digestive hemorrhage due to duodenal ulcer: the prevalence of the infection, the efficacy of 3 triple therapies and the role of eradication in preventing a hemorrhagic recurrence].
Gisbert JP; Boixeda D; Aller R; de la Serna C; Sanz E; Martín de Argila C; Abraira V; García Plaza A
Med Clin (Barc); 1999 Feb; 112(5):161-5. PubMed ID: 10091208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
